KM-391

KM-391 is a serotonin reuptake inhibitor which was under development for the treatment of autism but was never marketed.

Uses your system voice; voice and rate in settings.

Snapshot

≈ 1 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

KM-391 is a serotonin reuptake inhibitor which was under development for the treatment of autism but was never marketed. It is taken by mouth.

See also

Zolmitriptan § Social deficits and aggression

Text derived from https://en.wikipedia.org/w/index.php?oldid=1256621640 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

3 named source(s) extracted from the cited revision. A source with no author is shown by its publication; nothing is invented.